Data Foundry

Drug recalls 2012

Lidocaine HCl Injection — Class II drug recall D-099-2013

Terminated recall by Hospira, Inc., reported 2012-12-26, distributed nationwide. Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass w

Recall numberD-099-2013
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmHospira, Inc., Lake Forest, IL, United States
Recall initiated2012-10-04
Classified2012-12-20
Reported by FDA2012-12-26
Terminated2014-05-08
DistributedNationwide (US)
Quantity120,350 vials
Reason classesforeign material, specification failure
NDC00409-4275, 00409-4275-01, 00409-4275-16, 00409-4276, 00409-4276-01, 00409-4276-02, 00409-4276-16, 00409-4276-17, 00409-4277, 00409-4277-01, 00409-4277-02, 00409-4277-16, 00409-4277-17, 00409-4278, 00409-4278-01, 00409-4278-16, 00409-4279, 00409-4279-02, 00409-4279-16, 00409-4282, 00409-4282-01, 00409-4282-02, 00409-4282-11, 00409-4282-12, 00409-4282-25 and 14 more
Expiration dates2014-02-01

Product

Lidocaine HCl Injection, USP, 1% (10 mg/mL), 30 mL Single-dose Teartop Vial, packaged in 25-count vials per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-4279-02.

Reason for recall

Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in the product.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-099-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.